Background Major issues in the implementation of screening for lung cancer by means of
low-dose computed tomography (CT) are the definition of a positive result and the …

Purpose This report describes the quality of life (QOL) findings of a randomized placebo
controlled study of erlotinib, an epidermal growth factor receptor inhibitor, in patients with non–…

… Shepherd, Mircea Dediu, Tudor-Eliade Ciuleanu, David Fenton, Mauro Zukin, David Walde,
Francis Laberge, Mark D. Vincent, Peter M. Ellis, Scott A. … Shepherd, Mircea Dediu, Tudor-Eliade …

Background Results from retrospective studies indicate that selecting individuals for low-dose
CT lung cancer screening on the basis of a highly predictive risk model is superior to using …

PURPOSE To evaluate the roles of granisetron and dexamethasone for emesis control on
days 2 through 7 after the administration of cisplatin in doses of 50 mg/m2 or greater to …

Introduction Malignant pleural mesothelioma (MPM) is an aggressive malignancy that most
often presents at an advanced, incurable stage. After the failure of standard first-line cisplatin/…

Background Lung cancer screening with low-dose CT (LDCT) scan has been demonstrated
to reduce lung cancer mortality. Preliminary reports suggested that up to 20% of lung …

To our knowledge, no study has clearly demonstrated the advantage of sedative premedication
for bronchoscopy. In a double-blind study, we evaluated the efficacy of oral lorazepam …

Objectives The impact of lung cancer screening with low-dose chest CT (LDCT) on participants’
anxiety levels and health-related quality of life (HRQoL) is an important consideration in …

AE-941 (Neovastat®), an antiangiogenic component extracted from cartilage, selectively
competes for the binding of vascular endothelial growth factor to its receptor, inhibits matrix …